Commentary

Video

Dr Kutikov on Therapeutic Approaches in Urothelial Cancer Requiring Cystectomy

Author(s):

Alexander Kutikov, MD, FACS
Conference|American Urological Association Annual Meeting

Alexander Kutikov, MD, FACS, discusses treatment options for patients with urothelial cancer requiring cystectomy.

Alexander Kutikov, MD, FACS, chair and professor, Department of Urology and the Roberta R. Scheller Chair in Urologic Oncology at Fox Chase Cancer Center, discusses treatment options for patients with urothelial cancer requiring cystectomy.

Related Videos
Yair Lotan, MD, UT Southwestern Medical Center
Terence W. Friedlander, MD
Terence W. Friedlander, MD
John K. Lee, MD, PhD
Guru P. Sonpavde, MD
Guru P. Sonpavde, MD
Binod Dhakal, MD
Jill Corre, PharmD, PhD
Saad Z. Usmani, MD, MBA, FACP, FASCO
Ashraf Z. Badros, MBCHB
Related Content
RVU120 in R/R Metastatic or Advanced Solid Tumors | Image Credit: © tonstock - stock.adobe.com
October 28th 2024

RVU120 Shows Early Promise in R/R Metastatic or Advanced Solid Tumors

Oncology Unplugged
August 7th 2024

Park and Grivas Expand on Treatment Updates in Bladder Cancer

APR-1051 in Advanced, Mutated Solid Tumors | Image Credit: © tonstock - stock.adobe.com
October 25th 2024

The WEE1 Inhibitor APR-1051 Shows Early Safety and Tolerability in Advanced, Mutated Solid Tumors

Oncology Unplugged
July 24th 2024

Park and Sonpavde on Sacituzumab Govitecan Plus Enfortumab Vedotin in Metastatic Urothelial Cancer

Allison A. Aggon, DO, FACOS, Associate Professor, Division of Breast Surgery, Department of Surgery, Fox Chase Cancer Center
October 24th 2024

Fox Chase Cancer Center’s Dr. Allision Aggon Receives Earth Angel Award From Breast Cancer Nonprofit Organization

Yair Lotan, MD, professor, urology, chief, Urologic Oncology, Jane and John Justin Distinguished Chair in Urology, UT Southwestern Medical Center
October 24th 2024

Investigative Targeted Agents Are Set to Expand the BCG-Unresponsive NMIBC Treatment Paradigm